Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: INDIVIDUALISED HOMOEOPATHIC MEDICINE: INDIVIDUALISED HOMOEOPATHIC MEDICINES FOR 6 MONTHS BASED ON SYMPTOM SIMILARITY
Control Intervention1: NIL: NIL
Sponsors
NATIONAL INSTITUTE OF HOMOEOPATHY
Eligibility
Inclusion criteria
Inclusion criteria: Individuals diagnosed with Allergic Rhinitis, meeting the diagnostic guidelines outlined by the ARIA (Allergic Rhinitis and Its Impact on Asthma) classification. Serum IgE level greater than 100 IU/ml. Participants aged between 18 and 60 years. Individuals from all religious, caste, and socio-economic backgrounds. All genders will be considered for inclusion. Participants must be willing to provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Individuals diagnosed with life-threatening illnesses or uncontrolled systemic diseases that may compromise quality of life or involve any vital organ systems. Patients presenting with major complications or co-morbid conditions such as asthma or sinusitis. Individuals with a history of substance abuse or dependency. Pregnant or lactating women, as well as those planning to conceive during the study period. Patients who have received homoeopathic treatment for any chronic condition within the past one month. Individuals who are unwilling or unable to provide informed consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum IMMUNOGLOBULIN-E LEVEL (S. Ig-E)Timepoint: baseline to 6months | — |
Secondary
| Measure | Time frame |
|---|---|
| RQLQ RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRETimepoint: baseline to 6months | — |
Countries
India
Contacts
Public ContactDR SYED AFSAR ALI
National Institute of Homeopathy
Outcome results
None listed